A Multicentre Randomized Clinical Trial on Efficacy and Safety of Huxin Formula in Patients Undergoing Percutaneous Coronary Intervention

Percutaneous coronary intervention (PCI) is widely used in clinical treatment of coronary artery disease. However, the effects of PCI on preventing restenosis after revascularization and improving the quality of life were not satisfying. Huxin Formula is formulated by modifying an experienced Chines...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Huan-Lin, Wang, Yun-Fei, Li, Jun-Zhe, Zhang, Min-Zhou, Sheng, Xiao-Gang, Wang, Xia, Li, Song, Chen, Qiu-Xiong, Li, Xiao-Qing, Ou, Ai-hua, Ruan, Xin-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058264/
https://www.ncbi.nlm.nih.gov/pubmed/24971144
http://dx.doi.org/10.1155/2014/143064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058264/
https://www.ncbi.nlm.nih.gov/pubmed/24971144
http://dx.doi.org/10.1155/2014/143064

Ejemplares similares